Mitochondria dysfunction induced by decyl-TPP mitochondriotropic antioxidant based on caffeic acid AntiOxCIN<sub>6</sub> sensitizes cisplatin lung anticancer therapy due to a remodeling of energy metabolism

Publication date: Available online 29 November 2023Source: Biochemical PharmacologyAuthor(s): Ricardo Amorim, Carina C. Magalhães, Sofia Benfeito, Fernando Cagide, Ludgero C. Tavares, Katia Santos, Vilma A. Sardão, Sandipan Datta, Gino A. Cortopassi, I…

Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with <em>B-raf</em> inhibitor vemurafenib

Publication date: Available online 29 November 2023Source: Biochemical PharmacologyAuthor(s): Paola Orlandi, Marta Banchi, Francesca Vaglini, Marco Carli, Stefano Aringhieri, Arianna Bandini, Carla Pardini, Cristina Viaggi, Michele Lai, Greta Alì, Ales…